NEUROLOGY16

Download the app

Or search “NEUROLOGY16” in your Apple App or Google Play store.

The Lancet Neurology Conference 2016

19-21 October 2016 | London, United Kingdom

The clinical symptoms of neurodegenerative diseases arise years after the onset of neuronal damage. By the time the patient receives a diagnosis, it might be too late to intervene and modify the advanced pathological state of disease. Researchers are now focusing on preventing and stopping the pathological processes in the brain at an earlier, asymptomatic state.

This conference aims to disseminate cutting-edge findings on preclinical neurodegenerative diseases—including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease. The event will provide a unique platform for specialists to come together across disciplines for an authoritative discussion of the methodological, regulatory, and ethical considerations of research in people at asymptomatic states of neurodegenerative disease.

A high level invited oral programme, supplemented by contributed posters will provide a complete update on the latest research and thinking on the following topics:

  • Genetic factors, cellular pathways, and neuronal vulnerability
  • Environmental factors, epidemiology, and primary prevention
  • Biomarkers and early diagnosis
  • Prevention through therapeutics
  • Trials; regulatory and ethical considerations

The event will also have a translational focus, exploring genetic susceptibility, epidemiology and risk factors, neuronal vulnerability, biomarkers and early diagnosis, and disease prevention in healthy individuals with both pharmacological and non-pharmacological interventions.

Attendance at this meeting will enable you to:

  • Be part of a rich scientific programme incorporating the latest developments in preclinical neurodegenerative diseases
  • Understand the shift towards prevention and early diagnosis of neurodegenerative disease as the future of research in the field
  • Join key opinion leaders in discussing regulatory and ethical implications of this research in clinical practice.
  • Network with speakers and other leading experts across disciplines.